Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CMKLR2 antisense RNA (CMKLR2-AS, GPR1AS) is a non-coding RNA gene located adjacent to a differentially methylated region and believed to be involved in imprinting and possibly epigenetic regulation. It does not encode a receptor or protein, and there is currently no evidence for its direct role in signal transduction, disease, or drug interaction. It may be referenced in contexts involving gene expression regulation rather than pharmacologic targeting, and is not a receptor, enzyme, transporter, or conventional therapeutic target[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CMKLR2 antisense RNA (CMKLR2-AS).